Sign inGet started

Avoro Ventures LLC

Insider CIK 1879253 · AADI Director, 10% owner · SCTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SCTX Scribe Therapeutics, Inc. P Buy2026-07-282026-07-287,905$18.25 $144.3K3,088,888SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-282026-07-287,905$18.25 $144.3K3,088,888SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-242026-07-282,333,333$15.00 $35.00M3,030,983SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-242026-07-2850,000$22.31 $1.12M3,080,983SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-242026-07-2850,000$22.31 $1.12M3,080,983SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-242026-07-282,333,333$15.00 $35.00M3,030,983SEC↗
SCTX Scribe Therapeutics, Inc. A Award deriv2026-07-232026-07-2714,725— $014,725SEC↗
WHWK Whitehawk Therapeutics, In A Award deriv2026-06-122026-06-1538,040— $038,040SEC↗
WHWK Whitehawk Therapeutics, In A Award deriv2026-05-122026-05-146,377,714$3.92 $25.00M14,710,714SEC↗
WHWK Whitehawk Therapeutics, In A Award deriv2025-06-122025-06-1640,006— $040,006SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2025-02-282025-03-048,333,000$2.40 $20.00M8,333,000SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2024-06-122024-06-1445,832— $045,832SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2023-06-152023-06-2028,255— $028,255SEC↗
AADI Aadi Bioscience, Inc. A Award2022-09-222022-09-261,260,000$12.50 $15.75M3,471,752SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2022-06-152022-06-1718,573— $018,573SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2021-08-272021-08-3017,549— $017,549SEC↗
AADI Aadi Bioscience, Inc. A Award2021-08-262021-08-301,911,752$13.08 $25.01M2,211,752SEC↗